Skip to main content
. 2025 Oct 3;13(10):2422. doi: 10.3390/biomedicines13102422
HF Heart Failure
HFrEF Heart Failure with Reduced Ejection Fraction
HFpEF Heart Failure with Preserved Ejection Fraction
HFmrEF Heart Failure with Mildly Reduced Ejection Fraction
SGLT2 Sodium-Glucose Cotransporter-2
T2DM Type 2 Diabetes Mellitus
NT-proBNP N-terminal pro-B-type Natriuretic Peptide
eGFR Estimated Glomerular Filtration Rate
KCCQ Kansas City Cardiomyopathy Questionnaire
6MWD 6-Minute Walk Distance
RAASi Renin–Angiotensin–Aldosterone System Inhibitor
MRA Mineralocorticoid Receptor Antagonist
ARNI Angiotensin Receptor–Neprilysin Inhibitor
AHF Acute Heart Failure
MI Myocardial Infarction
LV Left Ventricle
LVEF Left Ventricular Ejection Fraction
QALY Quality-Adjusted Life Year
ICER Incremental Cost-Effectiveness Ratio
NYHA New York Heart Association
GDMT Guideline-Directed Medical Therapy
euDKA Euglycemic Diabetic Ketoacidosis
UTI Urinary Tract Infection
nsMRA Nonsteroidal Mineralocorticoid Receptor Antagonist